Seeking Alpha

Jazz to acquire Gentium in $1B deal

  • A Jazz Pharmaceuticals (JAZZ) subsidiary is set to offer $57 per share for Gentium (GENT), a slight premium to today's close of $55.65. (PR)
  • It's been a nice YTD run for GENT, which traded for around $11.50 in January.
Comments (1)
    , contributor
    Comments (223) | Send Message
    so this means we automatically get a sum of cash for our shares and we get no shares from jazz or do we to have to sell our shares for the set price or be SOL?
    19 Dec 2013, 05:12 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: